Herein, the strategy for directing BTZ to NSCLC cells hinges on the specific interaction between the cell surface receptor ACE2 and the SARS-CoV-2 spike receptor-binding domain (RBD) (25). The gene discussed is CASC3; the disease is non-small cell lung carcinoma.